Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes
暂无分享,去创建一个
Wely B. Floriano | Rhiannon L. Kamstra | Saedeh Dadgar | John Wigg | Morshed A. Chowdhury | Christopher P. Phenix | W. Floriano | M. Chowdhury | C. P. Phenix | Rhiannon L. Kamstra | S. Dadgar | J. Wigg
[1] K. Bhatia,et al. Uses of botulinum toxin injection in medicine today , 2000, BMJ : British Medical Journal.
[2] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..
[3] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[4] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[5] M. Mezei,et al. Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.
[6] Woo Kyung Moon,et al. A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.
[7] I. Johnson,et al. The molecular probes handbook : a guide to fluorescent probes and labeling technologies , 2010 .
[8] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[9] Andrew J. S. Knox,et al. Unbiasing Scoring Functions: A New Normalization and Rescoring Strategy. , 2007 .
[10] Torsten Witte,et al. Autoantibody Detection Using Indirect Immunofluorescence on HEp‐2 Cells , 2009, Annals of the New York Academy of Sciences.
[11] Etienne Weiss,et al. Therapeutic antibodies: successes, limitations and hopes for the future , 2009, British journal of pharmacology.
[12] M. Jolley. Fluorescence Polarization Assays for the Detection of Proteases and Their Inhibitors , 1996 .
[13] Wely B. Floriano,et al. Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A. , 2013, Journal of medicinal chemistry.
[14] Nagarajan Vaidehi,et al. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. , 2004, Journal of medicinal chemistry.
[15] Enno Schmidt,et al. Modern diagnosis of autoimmune blistering skin diseases. , 2010, Autoimmunity reviews.
[16] Alexander M. Lewis,et al. Identification of a chemical probe for NAADP by virtual screening , 2009, Nature chemical biology.
[17] M. Scheffner,et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.
[18] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[19] Mitchell A. Avery,et al. Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library , 2011, J. Chem. Inf. Model..
[20] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[21] Markus Sauer,et al. Spectroscopic study and evaluation of red-absorbing fluorescent dyes. , 2003, Bioconjugate chemistry.
[22] Yvonne A. Evrard,et al. Preclinical elopment of a Validated Immunofluorescence Assay γ H 2 AX as a Pharmacodynamic Marker of R oisomerase I Inhibitor Activity , 2010 .
[23] R. Stevens,et al. Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. , 2011, Journal of medicinal chemistry.
[24] W. Checovich,et al. Fluorescence polarization — a new tool for cell and molecular biology , 1995, Nature.
[25] R. Tsien,et al. The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.
[26] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[27] C. J. Lewis,et al. Cyanine Dye Labeling Reagents: Sulfoindocyanine Succinimidyl Esters. , 1993 .
[28] B. Shoichet,et al. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.
[29] U. Panzer,et al. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] Jerome Hauer,et al. Botulinum toxin as a biological weapon , 2001 .
[31] S. R. Parker,et al. Cyanine dye labeling reagents--carboxymethylindocyanine succinimidyl esters. , 1990, Cytometry.
[32] Thomas A. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[33] R. Weissleder,et al. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.
[34] J. Sobel,et al. Foodborne Botulism in the United States, 1990–2000 , 2004, Emerging infectious diseases.
[35] Peter Kolb,et al. Structure-based discovery of β2-adrenergic receptor ligands , 2009, Proceedings of the National Academy of Sciences.
[36] U. Sack,et al. [Autoantibody detection by indirect immunofluorescence on HEp-2 cells]. , 2009, Deutsche medizinische Wochenschrift.
[37] M. Allen,et al. High Throughput Fluorescence Polarization: A Homogeneous Alternative to Radioligand Binding for Cell Surface Receptors , 2000, Journal of biomolecular screening.
[38] Anders Karlén,et al. Ligand Bias of Scoring Functions in Structure-Based Virtual Screening , 2006, J. Chem. Inf. Model..
[39] John B. O. Mitchell,et al. Scoring functions and enrichment: a case study on Hsp90 , 2007, BMC Bioinform..
[40] W. Floriano,et al. Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A). , 2015, Molecular and cellular probes.
[41] Brian K. Shoichet,et al. Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1 B , 2022 .
[42] S. Achilefu,et al. Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range. , 2005, Chemical communications.
[43] Philip K. Russell,et al. Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.
[44] Shuowei Cai,et al. Botulism Diagnostics: From Clinical Symptoms to in vitro Assays , 2007, Critical reviews in microbiology.
[45] Ralph Weissleder,et al. Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.
[46] Ralph Weissleder,et al. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.
[47] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[48] M. Scheffner,et al. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. , 1991, The EMBO journal.
[49] Alexander D. MacKerell,et al. Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..
[50] E. Lazarides,et al. Actin antibody: the specific visualization of actin filaments in non-muscle cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Riggs,et al. Isothiocyanate compounds as fluorescent labeling agents for immune serum. , 1958, The American journal of pathology.
[52] J. Jankovic,et al. Botulinum toxin in clinical practice , 2004, Journal of Neurology, Neurosurgery & Psychiatry.